Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios and Their Relation with Disease Activity in Systemic Lupus Erythematosus Patients

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Marker of Disease Activity in Rheumatoid Arthritis

Can Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Tumor Necrosis Factor Alpha Predict Lupus Nephritis Flares?

Neutrophil-Lymphocyte Ratio and Platelat-Lymphocyte Ratio as Potential Markers of Disease Activity in Patients with Axial Spondyloarthritis

Assessment of Neutrophil Lymphocyte Ratio in Systemic Sclerosis Patients in Tanta University Hospital: A Promising Marker in Predicting Disease Severity

Study of the Predictive Value of Neutrophil/Lymphocyte Ratio in Diagnosis of COVID-19 Infection

Neutrophil-to-Lymphocyte Ratio as a Novel Marker for Early Detection of Hypertensive Nephropathy and as a Predictor of Worsening Renal Functions in Hypertensive Patients

Neutrophil CD64 in diagnosis of infection in systemic lupus erythematosus patients

Neutrophil-Lymphocyte and Platelet-Lymphocyte ratios as a marker for diabetes control and complications.

Neutrophil-Lymphocyte Ratio as A predictor Inflammatory Marker for Microvascular Complications of Type 2 Diabetes